U.S. FDA issues seven observations to Dr. Reddy’s biologics manufacturing facility in Hyderabad
“The observations will be addressed within the stipulated timeline,” the generic drugmaker said. File | Photo Credit: Getty Images/iStockphoto The U.S. Food and Drug Administration (USFDA) has issued seven observations to the biologics manufacturing facility of Dr. Reddy’s Laboratories in Bachupally, Hyderabad. “A Form 483 with the seven observations was issued to the facility on…
